Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5Neoplasms 3Prostatic Neoplasms 2Pain, Postoperative 2Pain 2Neuroma 2Chronic Pain 2Breast Diseases 2Wounds and Injuries 1Stroke 1Stomach Neoplasms 1Spinal Cord Injuries 1Skin Diseases 1Rectal Neoplasms 1Prostatic Hyperplasia 1Pancreatic Neoplasms 1Neoplasms by Site 1Muscular Atrophy 1Muscle Spasticity 1Lower Urinary Tract Symptoms 1Low Anterior Resection Syndrome 1Hereditary leiomyomatosis and renal cell cancer 1Head and Neck Neoplasms 1Gastroparesis 1Ganglion Cysts 1Esophageal Neoplasms 1Esophageal Motility Disorders 1Esophageal Diseases 1Esophageal Achalasia 1Cluster Headache 1

Interventions

Oxaliplatin 295Capecitabine 209Fluorouracil 183Cisplatin 172Docetaxel 140S 1 (combination) 135Paclitaxel 128Leucovorin 117Irinotecan 110pembrolizumab 104Trastuzumab 75Nivolumab 59apatinib 57Drug Therapy 52sintilimab 46Surgical Procedures, Operative 45Ramucirumab 40Radiotherapy 40Bevacizumab 37Hyperthermic Intraperitoneal Chemotherapy 34Epirubicin 32titanium silicide 31tislelizumab 31Carboplatin 31Gastrectomy 28Cyclophosphamide 27XELOX 25Tegafur 24Folfox protocol 23Albumin-Bound Paclitaxel 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Botulinum Toxins, Type A × Clear all
NCT01822210 2018-03-09

Botulinum Toxin for Stomach Cancer Treatment

St. Olavs Hospital

Phase 2 Completed
7 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡